@article{nucifora2017,
	title = {Clozapine as a Model for Antipsychotic Development},
	author = {Nucifora, Frederick C. and Mihaljevic, Marina and Lee, Brian J. and Sawa, Akira},
	year = {2017},
	month = {07},
	date = {2017-07},
	journal = {Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics},
	pages = {750--761},
	volume = {14},
	number = {3},
	doi = {10.1007/s13311-017-0552-9},
	note = {PMID: 28653280
PMCID: PMC5509641},
	langid = {eng}
}

@article{hippius1999,
	title = {A historical perspective of clozapine},
	author = {Hippius, H.},
	year = {1999},
	date = {1999},
	journal = {The Journal of Clinical Psychiatry},
	pages = {22--23},
	volume = {60 Suppl 12},
	note = {PMID: 10372606},
	langid = {eng}
}

@article{crilly2007,
	title = {The history of clozapine and its emergence in the US market: a review and analysis},
	author = {Crilly, John},
	year = {2007},
	month = {03},
	date = {2007-03},
	journal = {History of Psychiatry},
	pages = {39--60},
	volume = {18},
	number = {1},
	doi = {10.1177/0957154X07070335},
	note = {PMID: 17580753},
	langid = {eng}
}

@article{kane1988,
	title = {Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine},
	author = {Kane, J. and Honigfeld, G. and Singer, J. and Meltzer, H.},
	year = {1988},
	month = {09},
	date = {1988-09},
	journal = {Archives of General Psychiatry},
	pages = {789--796},
	volume = {45},
	number = {9},
	doi = {10.1001/archpsyc.1988.01800330013001},
	note = {PMID: 3046553},
	langid = {eng}
}

@article{meltzer2003,
	title = {Clozapine Treatment for Suicidality in SchizophreniaInternational Suicide Prevention Trial (InterSePT)},
	author = {Meltzer, Herbert Y.},
	year = {2003},
	month = {01},
	date = {2003-01-01},
	journal = {Archives of General Psychiatry},
	pages = {82},
	volume = {60},
	number = {1},
	doi = {10.1001/archpsyc.60.1.82},
	url = {http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archpsyc.60.1.82},
	langid = {en}
}

@article{bastiampillai2016,
	title = {Changes for clozapine monitoring in the United States},
	author = {Bastiampillai, T. and Gupta, A. and Chan, S. K. W. and Allison, S.},
	year = {2016},
	month = {07},
	date = {2016-07},
	journal = {Molecular Psychiatry},
	pages = {858--860},
	volume = {21},
	number = {7},
	doi = {10.1038/mp.2016.66},
	note = {PMID: 27137744},
	langid = {eng}
}

@article{aksoypoyraz2015,
	title = {Effectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case series},
	author = {Aksoy Poyraz, Cana and Turan, {{\c{S}}enol} and Demirel, {Ömer Faruk} and {Usta Sa{\u{g}}lam}, Nazife Gamze and {Y{\i}ld{\i}z}, {Naz{\i}m} and Duran, Alaattin},
	year = {2015},
	month = {08},
	date = {2015-08},
	journal = {Therapeutic Advances in Psychopharmacology},
	pages = {237--242},
	volume = {5},
	number = {4},
	doi = {10.1177/2045125315584871},
	note = {PMID: 26301080
PMCID: PMC4535045},
	langid = {eng}
}

@article{devinsky1991,
	title = {Clozapine-related seizures},
	author = {Devinsky, O. and Honigfeld, G. and Patin, J.},
	year = {1991},
	month = {03},
	date = {1991-03},
	journal = {Neurology},
	pages = {369--371},
	volume = {41},
	number = {3},
	doi = {10.1212/wnl.41.3.369},
	note = {PMID: 2006003},
	langid = {eng}
}

@article{varma2011,
	title = {Clozapine-related EEG changes and seizures: dose and plasma-level relationships},
	author = {Varma, Seema and Bishara, Delia and Besag, Frank M. C. and Taylor, David},
	year = {2011},
	month = {04},
	date = {2011-04},
	journal = {Therapeutic Advances in Psychopharmacology},
	pages = {47--66},
	volume = {1},
	number = {2},
	doi = {10.1177/2045125311405566},
	note = {PMID: 23983927
PMCID: PMC3736902},
	langid = {eng}
}

@article{ingimarsson2016,
	title = {Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland},
	author = {Ingimarsson, Oddur and MacCabe, James H. and Haraldsson, {Magnús} and {Jónsdóttir}, {Halldóra} and Sigurdsson, Engilbert},
	year = {2016},
	month = {12},
	date = {2016-12},
	journal = {BMC Psychiatry},
	pages = {441},
	volume = {16},
	number = {1},
	doi = {10.1186/s12888-016-1167-0},
	url = {http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-1167-0},
	langid = {en}
}

@article{kang2001,
	title = {Non-linear dynamic analysis of clozapine-induced electroencephalographic changes in schizophrenic patients - a preliminary study},
	author = {Kang, Ung Gu and Park, Kyung-Tae and Ahn, Yong Min and Koo, Young Jin and Yoon, Se Chang and Yi, Sang-Hoon and Kim, Yong Sik},
	year = {2001},
	month = {08},
	date = {2001-08},
	journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
	pages = {1229--1239},
	volume = {25},
	number = {6},
	doi = {10.1016/S0278-5846(01)00183-X},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S027858460100183X},
	langid = {en}
}

@article{røge2012,
	title = {Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?},
	author = {{Røge}, Rasmus and {Møller}, Bjarne K. and Andersen, Christian R. and Correll, Christoph U. and Nielsen, Jimmi},
	year = {2012},
	month = {09},
	date = {2012-09},
	journal = {Schizophrenia Research},
	pages = {204--213},
	volume = {140},
	number = {1-3},
	doi = {10.1016/j.schres.2012.06.020},
	note = {PMID: 22831769},
	langid = {eng}
}

@article{mckinnon2009,
	title = {Clozapine-induced bowel infarction: a case report},
	author = {McKinnon, Nicholas D. and Azad, Alvi and Waters, Brian M. and Joshi, Kaustubh G.},
	year = {2009},
	month = {03},
	date = {2009-03},
	journal = {Psychiatry (Edgmont (Pa.: Township))},
	pages = {30--35},
	volume = {6},
	number = {3},
	note = {PMID: 19724752
PMCID: PMC2719458},
	langid = {eng}
}

@article{pillinger2020,
	title = {Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis},
	author = {Pillinger, Toby and McCutcheon, Robert A and Vano, Luke and Mizuno, Yuya and Arumuham, Atheeshaan and Hindley, Guy and Beck, Katherine and Natesan, Sridhar and Efthimiou, Orestis and Cipriani, Andrea and Howes, Oliver D},
	year = {2020},
	month = {01},
	date = {2020-01},
	journal = {The Lancet Psychiatry},
	pages = {64--77},
	volume = {7},
	number = {1},
	doi = {10.1016/S2215-0366(19)30416-X},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S221503661930416X},
	langid = {en}
}

@article{colpaert2003,
	title = {Discovering risperidone: the LSD model of psychopathology},
	author = {Colpaert, Francis C.},
	year = {2003},
	month = {04},
	date = {2003-04},
	journal = {Nature Reviews Drug Discovery},
	pages = {315--320},
	volume = {2},
	number = {4},
	doi = {10.1038/nrd1062},
	url = {http://www.nature.com/articles/nrd1062},
	langid = {en}
}

@article{meltzer1989,
	title = {The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs},
	author = {Meltzer, H. Y. and Matsubara, S. and Lee, J. C.},
	year = {1989},
	date = {1989},
	journal = {Psychopharmacology Bulletin},
	pages = {390--392},
	volume = {25},
	number = {3},
	note = {PMID: 2576319},
	langid = {eng}
}

@article{luchins1998,
	title = {Alteration in the Recommended Dosing Schedule for Risperidone},
	author = {Luchins, Daniel J. and Klass, David and Hanrahan, Patricia and Malan, Randy and Harris, John},
	year = {1998},
	month = {03},
	date = {1998-03},
	journal = {American Journal of Psychiatry},
	pages = {365--366},
	volume = {155},
	number = {3},
	doi = {10.1176/ajp.155.3.365},
	url = {http://psychiatryonline.org/doi/abs/10.1176/ajp.155.3.365},
	langid = {en}
}

@article{nyberg1999,
	title = {Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients},
	author = {Nyberg, S. and Eriksson, B. and Oxenstierna, G. and Halldin, C. and Farde, L.},
	year = {1999},
	month = {06},
	date = {1999-06},
	journal = {The American Journal of Psychiatry},
	pages = {869--875},
	volume = {156},
	number = {6},
	doi = {10.1176/ajp.156.6.869},
	note = {PMID: 10360125},
	langid = {eng}
}

@article{farde1992,
	title = {Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects},
	author = {Farde, L. and {Nordström}, A. L. and Wiesel, F. A. and Pauli, S. and Halldin, C. and Sedvall, G.},
	year = {1992},
	month = {07},
	date = {1992-07},
	journal = {Archives of General Psychiatry},
	pages = {538--544},
	volume = {49},
	number = {7},
	doi = {10.1001/archpsyc.1992.01820070032005},
	note = {PMID: 1352677},
	langid = {eng}
}

@article{kapur1999,
	title = {Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia},
	author = {Kapur, S. and Zipursky, R. B. and Remington, G.},
	year = {1999},
	month = {02},
	date = {1999-02},
	journal = {The American Journal of Psychiatry},
	pages = {286--293},
	volume = {156},
	number = {2},
	doi = {10.1176/ajp.156.2.286},
	note = {PMID: 9989565},
	langid = {eng}
}

@article{leucht2021,
	title = {Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia: A Meta-analysis},
	author = {Leucht, Stefan and Bauer, Sofia and Siafis, Spyridon and Hamza, Tasnim and Wu, Hui and Schneider-Thoma, Johannes and Salanti, Georgia and Davis, John M.},
	year = {2021},
	month = {11},
	date = {2021-11-01},
	journal = {JAMA Psychiatry},
	pages = {1238},
	volume = {78},
	number = {11},
	doi = {10.1001/jamapsychiatry.2021.2130},
	url = {https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2783296},
	langid = {en}
}

@article{kearns2000,
	title = {Risperidone-associated hyperprolactinemia},
	author = {Kearns, A. E. and Goff, D. C. and Hayden, D. L. and Daniels, G. H.},
	year = {2000},
	month = {12},
	date = {2000-12},
	journal = {Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists},
	pages = {425--429},
	volume = {6},
	number = {6},
	doi = {10.4158/EP.6.6.425},
	note = {PMID: 11155212},
	langid = {eng}
}

@article{lay2012,
	title = {Rabbit syndrome and akathisia in a patient treated with risperidone},
	author = {Lay, C and Spisla, C},
	year = {2012},
	month = {09},
	date = {2012-09-14},
	journal = {Pharmacopsychiatry},
	volume = {45},
	number = {06},
	doi = {10.1055/s-0032-1326758},
	url = {http://www.thieme-connect.de/DOI/DOI?10.1055/s-0032-1326758},
	langid = {en}
}

@article{pringsheim2018,
	title = {The Assessment and Treatment of Antipsychotic-Induced Akathisia},
	author = {Pringsheim, Tamara and Gardner, David and Addington, Donald and Martino, Davide and Morgante, Francesca and Ricciardi, Lucia and Poole, Norman and Remington, Gary and Edwards, Mark and Carson, Alan and Barnes, Thomas R. E.},
	year = {2018},
	month = {11},
	date = {2018-11},
	journal = {The Canadian Journal of Psychiatry},
	pages = {719--729},
	volume = {63},
	number = {11},
	doi = {10.1177/0706743718760288},
	url = {http://journals.sagepub.com/doi/10.1177/0706743718760288},
	langid = {en}
}

@article{fang1999,
	title = {Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4},
	author = {Fang, J. and Bourin, M. and Baker, G. B.},
	year = {1999},
	month = {02},
	date = {1999-02},
	journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
	pages = {147--151},
	volume = {359},
	number = {2},
	doi = {10.1007/pl00005334},
	note = {PMID: 10048600},
	langid = {eng}
}

@article{spina2007,
	title = {Metabolic Drug Interactions with Newer Antipsychotics: A Comparative Review},
	author = {Spina, Edoardo and de Leon, Jose},
	year = {2007},
	month = {01},
	date = {2007-01},
	journal = {Basic & Clinical Pharmacology & Toxicology},
	pages = {4--22},
	volume = {100},
	number = {1},
	doi = {10.1111/j.1742-7843.2007.00017.x},
	url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2007.00017.x},
	langid = {en}
}

@article{corenamcleod2015,
	title = {Comparative Pharmacology of Risperidone and Paliperidone},
	author = {Corena-McLeod, Maria},
	year = {2015},
	month = {06},
	date = {2015-06},
	journal = {Drugs in R&D},
	pages = {163--174},
	volume = {15},
	number = {2},
	doi = {10.1007/s40268-015-0092-x},
	note = {PMID: 25943458
PMCID: PMC4488186},
	langid = {eng}
}

@article{gahr2011,
	title = {Paliperidone extended-release: does it have a place in antipsychotic therapy?},
	author = {Gahr, Maximilian and {Kölle}, Markus A. and {Schönfeldt-Lecuona}, Carlos and Lepping, Peter and Freudenmann, Roland W.},
	year = {2011},
	month = {03},
	date = {2011-03-11},
	journal = {Drug Design, Development and Therapy},
	pages = {125--146},
	volume = {5},
	doi = {10.2147/DDDT.S17266},
	note = {PMID: 21448450
PMCID: PMC3063117},
	langid = {eng}
}

@article{kane1988,
	title = {Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine},
	author = {Kane, J. and Honigfeld, G. and Singer, J. and Meltzer, H.},
	year = {1988},
	month = {09},
	date = {1988-09},
	journal = {Archives of General Psychiatry},
	pages = {789--796},
	volume = {45},
	number = {9},
	doi = {10.1001/archpsyc.1988.01800330013001},
	note = {PMID: 3046553},
	langid = {eng}
}

@article{baldwin1995,
	title = {First clinical experience with olanzapine (LY 170053): results of an open-label safety and dose-ranging study in patients with schizophrenia},
	author = {Baldwin, D. S. and Montgomery, S. A.},
	year = {1995},
	month = {11},
	date = {1995-11},
	journal = {International Clinical Psychopharmacology},
	pages = {239--244},
	volume = {10},
	number = {4},
	note = {PMID: 8748045},
	langid = {eng}
}

@article{beasley1996,
	title = {Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial},
	author = {Beasley, C. M. and Sanger, T. and Satterlee, W. and Tollefson, G. and Tran, P. and Hamilton, S.},
	year = {1996},
	month = {03},
	date = {1996-03},
	journal = {Psychopharmacology},
	pages = {159--167},
	volume = {124},
	number = {1-2},
	doi = {10.1007/BF02245617},
	note = {PMID: 8935812},
	langid = {eng}
}

@article{beasleyolanzapine_1996,
	title = {Olanzapine versus {Placebo} and {Haloperidol}},
	volume = {14},
	issn = {0893-133X},
	url = {http://www.nature.com/doifinder/10.1016/0893-133X(95)00069-P},
	doi = {10.1016/0893-133X(95)00069-P},
	number = {2},
	urldate = {2022-04-29},
	journal = {Neuropsychopharmacology},
	author = {Beasley, Charles M and Tollefson, Gary and Tran, Pierre and Satterlee, Winston and Sanger, Todd and Hamilton, Susan},
	month = feb,
	year = {1996},
	pages = {111--123},
	file = {Full Text:C\:\\Users\\Ansel\\Zotero\\storage\\R5DM6USH\\Beasley et al. - 1996 - Olanzapine versus Placebo and Haloperidol.pdf:application/pdf},
}

@article{tollefson1997,
	title = {Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial},
	author = {Tollefson, G. D. and Beasley, C. M. and Tran, P. V. and Street, J. S. and Krueger, J. A. and Tamura, R. N. and Graffeo, K. A. and Thieme, M. E.},
	year = {1997},
	month = {04},
	date = {1997-04},
	journal = {The American Journal of Psychiatry},
	pages = {457--465},
	volume = {154},
	number = {4},
	doi = {10.1176/ajp.154.4.457},
	note = {PMID: 9090331},
	langid = {eng}
}

@article{kapur1998,
	title = {5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation},
	author = {Kapur, S. and Zipursky, R. B. and Remington, G. and Jones, C. and DaSilva, J. and Wilson, A. A. and Houle, S.},
	year = {1998},
	month = {07},
	date = {1998-07},
	journal = {The American Journal of Psychiatry},
	pages = {921--928},
	volume = {155},
	number = {7},
	doi = {10.1176/ajp.155.7.921},
	note = {PMID: 9659858},
	langid = {eng}
}

@article{kusumi2015,
	title = {Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis: Atypical antipsychotics},
	author = {Kusumi, Ichiro and Boku, Shuken and Takahashi, Yoshito},
	year = {2015},
	month = {05},
	date = {2015-05},
	journal = {Psychiatry and Clinical Neurosciences},
	pages = {243--258},
	volume = {69},
	number = {5},
	doi = {10.1111/pcn.12242},
	url = {https://onlinelibrary.wiley.com/doi/10.1111/pcn.12242},
	langid = {en}
}

@article{stockton1996,
	title = {Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons},
	author = {Stockton, M. E. and Rasmussen, K.},
	year = {1996},
	month = {02},
	date = {1996-02},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {97--105},
	volume = {14},
	number = {2},
	doi = {10.1016/0893-133X(94)00130-R},
	note = {PMID: 8822532},
	langid = {eng}
}

@article{volavka2004,
	title = {Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol},
	author = {Volavka, Jan and Czobor, Pal and Cooper, Thomas B. and Sheitman, Brian and Lindenmayer, Jean-Pierre and Citrome, Leslie and McEvoy, Joseph P. and Lieberman, Jeffrey A.},
	year = {2004},
	month = {01},
	date = {2004-01},
	journal = {The Journal of Clinical Psychiatry},
	pages = {57--61},
	volume = {65},
	number = {1},
	doi = {10.4088/jcp.v65n0109},
	note = {PMID: 14744169},
	langid = {eng}
}

@article{lieberman2005,
	title = {Effectiveness of antipsychotic drugs in patients with chronic schizophrenia},
	author = {Lieberman, Jeffrey A. and Stroup, T. Scott and McEvoy, Joseph P. and Swartz, Marvin S. and Rosenheck, Robert A. and Perkins, Diana O. and Keefe, Richard S. E. and Davis, Sonia M. and Davis, Clarence E. and Lebowitz, Barry D. and Severe, Joanne and Hsiao, John K. and {Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators}, },
	year = {2005},
	month = {09},
	date = {2005-09-22},
	journal = {The New England Journal of Medicine},
	pages = {1209--1223},
	volume = {353},
	number = {12},
	doi = {10.1056/NEJMoa051688},
	note = {PMID: 16172203},
	langid = {eng}
}

@article{brooks2008,
	title = {High Initial Dosing of Olanzapine for Stabilization of Acute Agitation: A Retrospective Case Series},
	author = {Brooks, John O and Karnik, Niranjan and Hoblyn, Jennifer},
	year = {2008},
	month = {01},
	date = {2008-01},
	journal = {Journal of Pharmacy Technology},
	pages = {7--11},
	volume = {24},
	number = {1},
	doi = {10.1177/875512250802400103},
	url = {http://journals.sagepub.com/doi/10.1177/875512250802400103},
	langid = {en}
}

@article{kinon2008,
	title = {Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆},
	author = {KINON, B and CHEN, L and ASCHERSVANUM, H and STAUFFER, V and KOLLACKWALKER, S and SNIADECKI, J and KANE, J},
	year = {2008},
	month = {07},
	date = {2008-07},
	journal = {Schizophrenia Research},
	pages = {230{\textendash}240},
	volume = {102},
	number = {1-3},
	doi = {10.1016/j.schres.2008.02.021},
	url = {http://dx.doi.org/10.1016/j.schres.2008.02.021}
}

@article{takeuchi2015,
	title = {Effectiveness of different dosing regimens of risperidone and olanzapine in schizophrenia},
	author = {Takeuchi, Hiroyoshi and Fervaha, Gagan and Lee, Jimmy and Agid, Ofer and Remington, Gary},
	year = {2015},
	month = {03},
	date = {2015-03},
	journal = {European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology},
	pages = {295--302},
	volume = {25},
	number = {3},
	doi = {10.1016/j.euroneuro.2014.12.008},
	note = {PMID: 25649680},
	langid = {eng}
}

@article{kennedy2000,
	title = {The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone},
	author = {Kennedy, John S. and Bymaster, Frank P. and Basson, Bruce R. and Gilmore, Julie A. and Tran, Pierre V.},
	year = {2000},
	month = {08},
	date = {2000-08},
	journal = {Primary Care Companion to the Journal of Clinical Psychiatry},
	pages = {122--126},
	volume = {2},
	number = {4},
	doi = {10.4088/pcc.v02n0403},
	note = {PMID: 15014645
PMCID: PMC181123},
	langid = {eng}
}

@article{miller2004,
	title = {Atypical antipsychotics: sleep, sedation, and efficacy},
	author = {Miller, Del D.},
	year = {2004},
	date = {2004},
	journal = {Primary Care Companion to the Journal of Clinical Psychiatry},
	pages = {3--7},
	volume = {6},
	number = {Suppl 2},
	note = {PMID: 16001094
PMCID: PMC487011},
	langid = {eng}
}

@article{rummelkluge2012,
	title = {Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons},
	author = {Rummel-Kluge, Christine and Komossa, Katja and Schwarz, Sandra and Hunger, Heike and Schmid, Franziska and Kissling, Werner and Davis, John M. and Leucht, Stefan},
	year = {2012},
	month = {01},
	date = {2012-01},
	journal = {Schizophrenia Bulletin},
	pages = {167--177},
	volume = {38},
	number = {1},
	doi = {10.1093/schbul/sbq042},
	note = {PMID: 20513652
PMCID: PMC3245581},
	langid = {eng}
}

@article{sheitman1997,
	title = {High-Dose Olanzapine for Treatment-Refractory Schizophrenia},
	author = {Sheitman, Brian B. and Lindgren, John C. and Early, John and Sved, Margie},
	year = {1997},
	month = {11},
	date = {1997-11},
	journal = {American Journal of Psychiatry},
	pages = {1626--1626},
	volume = {154},
	number = {11},
	doi = {10.1176/ajp.154.11.1626},
	url = {http://psychiatryonline.org/doi/abs/10.1176/ajp.154.11.1626},
	langid = {en}
}

@article{russell2001,
	title = {Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications},
	author = {Russell, J. M. and Mackell, J. A.},
	year = {2001},
	date = {2001},
	journal = {CNS drugs},
	pages = {537--551},
	volume = {15},
	number = {7},
	doi = {10.2165/00023210-200115070-00004},
	note = {PMID: 11510624},
	langid = {eng}
}

@article{allison1999,
	title = {Antipsychotic-induced weight gain: a comprehensive research synthesis},
	author = {Allison, D. B. and Mentore, J. L. and Heo, M. and Chandler, L. P. and Cappelleri, J. C. and Infante, M. C. and Weiden, P. J.},
	year = {1999},
	month = {11},
	date = {1999-11},
	journal = {The American Journal of Psychiatry},
	pages = {1686--1696},
	volume = {156},
	number = {11},
	doi = {10.1176/ajp.156.11.1686},
	note = {PMID: 10553730},
	langid = {eng}
}

@article{pillinger2017,
	title = {Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis},
	author = {Pillinger, Toby and Beck, Katherine and Gobjila, Cristian and Donocik, Jacek G. and Jauhar, Sameer and Howes, Oliver D.},
	year = {2017},
	month = {03},
	date = {2017-03-01},
	journal = {JAMA psychiatry},
	pages = {261--269},
	volume = {74},
	number = {3},
	doi = {10.1001/jamapsychiatry.2016.3803},
	note = {PMID: 28097367
PMCID: PMC6352957},
	langid = {eng}
}

@article{hirsch2017,
	title = {Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies},
	author = {Hirsch, Lauren and Yang, Jaeun and Bresee, Lauren and Jette, Nathalie and Patten, Scott and Pringsheim, Tamara},
	year = {2017},
	month = {09},
	date = {2017-09},
	journal = {Drug Safety},
	pages = {771--781},
	volume = {40},
	number = {9},
	doi = {10.1007/s40264-017-0543-0},
	url = {http://link.springer.com/10.1007/s40264-017-0543-0},
	langid = {en}
}

@article{gianfrancesco2002,
	title = {Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database},
	author = {Gianfrancesco, Frank D. and Grogg, Amy L. and Mahmoud, Ramy A. and Wang, Ruey-hua and Nasrallah, Henry A.},
	year = {2002},
	month = {10},
	date = {2002-10},
	journal = {The Journal of Clinical Psychiatry},
	pages = {920--930},
	volume = {63},
	number = {10},
	doi = {10.4088/jcp.v63n1010},
	note = {PMID: 12416602},
	langid = {eng}
}

@article{ulcickasyood2011,
	title = {Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?},
	author = {Ulcickas Yood, Marianne and Delorenze, Gerald N. and Quesenberry, Charles P. and Oliveria, Susan A. and Tsai, Ai-Lin and Kim, Edward and Cziraky, Mark J. and McQuade, Robert D. and Newcomer, John W. and {L'italien}, Gilbert J.},
	year = {2011},
	month = {12},
	date = {2011-12-15},
	journal = {BMC psychiatry},
	pages = {197},
	volume = {11},
	doi = {10.1186/1471-244X-11-197},
	note = {PMID: 22171594
PMCID: PMC3264670},
	langid = {eng}
}

@article{zhang2017,
	title = {The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis},
	author = {Zhang, Yangyu and Liu, Yingyu and Su, Yingying and You, Yueyue and Ma, Yue and Yang, Guang and Song, Yan and Liu, Xinyu and Wang, Mohan and Zhang, Lili and Kou, Changgui},
	year = {2017},
	month = {12},
	date = {2017-12},
	journal = {BMC Psychiatry},
	pages = {373},
	volume = {17},
	number = {1},
	doi = {10.1186/s12888-017-1539-0},
	url = {https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-017-1539-0},
	langid = {en}
}

@article{kreyenbuhl2010,
	title = {The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009},
	author = {Kreyenbuhl, Julie and Buchanan, Robert W. and Dickerson, Faith B. and Dixon, Lisa B. and {Schizophrenia Patient Outcomes Research Team (PORT)}, },
	year = {2010},
	month = {01},
	date = {2010-01},
	journal = {Schizophrenia Bulletin},
	pages = {94--103},
	volume = {36},
	number = {1},
	doi = {10.1093/schbul/sbp130},
	note = {PMID: 19955388
PMCID: PMC2800150},
	langid = {eng}
}

@article{sikich2008,
	title = {Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study},
	author = {Sikich, Linmarie and Frazier, Jean A. and McClellan, Jon and Findling, Robert L. and Vitiello, Benedetto and Ritz, Louise and Ambler, Denisse and Puglia, Madeline and Maloney, Ann E. and Michael, Emily and De Jong, Sandra and Slifka, Karen and Noyes, Nancy and Hlastala, Stefanie and Pierson, Leslie and McNamara, Nora K. and Delporto-Bedoya, Denise and Anderson, Robert and Hamer, Robert M. and Lieberman, Jeffrey A.},
	year = {2008},
	month = {11},
	date = {2008-11},
	journal = {The American Journal of Psychiatry},
	pages = {1420--1431},
	volume = {165},
	number = {11},
	doi = {10.1176/appi.ajp.2008.08050756},
	note = {PMID: 18794207},
	langid = {eng}
}

@article{czekalla2001,
	title = {Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis},
	author = {Czekalla, J. and Beasley, C. M. and Dellva, M. A. and Berg, P. H. and Grundy, S.},
	year = {2001},
	month = {03},
	date = {2001-03},
	journal = {The Journal of Clinical Psychiatry},
	pages = {191--198},
	volume = {62},
	number = {3},
	doi = {10.4088/jcp.v62n0310},
	note = {PMID: 11305706},
	langid = {eng}
}

@article{ring1996,
	title = {Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine},
	author = {Ring, B. J. and Catlow, J. and Lindsay, T. J. and Gillespie, T. and Roskos, L. K. and Cerimele, B. J. and Swanson, S. P. and Hamman, M. A. and Wrighton, S. A.},
	year = {1996},
	month = {02},
	date = {1996-02},
	journal = {The Journal of Pharmacology and Experimental Therapeutics},
	pages = {658--666},
	volume = {276},
	number = {2},
	note = {PMID: 8632334},
	langid = {eng}
}

@article{callaghan1999,
	title = {Olanzapine. Pharmacokinetic and pharmacodynamic profile},
	author = {Callaghan, J. T. and Bergstrom, R. F. and Ptak, L. R. and Beasley, C. M.},
	year = {1999},
	month = {09},
	date = {1999-09},
	journal = {Clinical Pharmacokinetics},
	pages = {177--193},
	volume = {37},
	number = {3},
	doi = {10.2165/00003088-199937030-00001},
	note = {PMID: 10511917},
	langid = {eng}
}

@article{freeman2009,
	title = {Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study},
	author = {Freeman, Darren J. and DiPaula, Bethany A. and Love, Raymond C.},
	year = {2009},
	month = {08},
	date = {2009-08},
	journal = {Pharmacotherapy},
	pages = {930--936},
	volume = {29},
	number = {8},
	doi = {10.1592/phco.29.8.930},
	note = {PMID: 19637946},
	langid = {eng}
}

@article{bushe2015,
	title = {Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice},
	author = {Bushe, Chris J and Falk, Deborah and Anand, Ernie and Casillas, Marta and Perrin, Elena and Chhabra-Khanna, Rashna and Detke, Holland C},
	year = {2015},
	month = {12},
	date = {2015-12},
	journal = {BMC Psychiatry},
	pages = {65},
	volume = {15},
	number = {1},
	doi = {10.1186/s12888-015-0450-9},
	url = {http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-015-0450-9},
	langid = {en}
}

@article{kapur2000,
	title = {A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy},
	author = {Kapur, S. and Zipursky, R. and Jones, C. and Shammi, C. S. and Remington, G. and Seeman, P.},
	year = {2000},
	month = {06},
	date = {2000-06},
	journal = {Archives of General Psychiatry},
	pages = {553--559},
	volume = {57},
	number = {6},
	doi = {10.1001/archpsyc.57.6.553},
	note = {PMID: 10839333},
	langid = {eng}
}

@article{chengappa2003,
	title = {A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study},
	author = {Chengappa, K. N. Roy and Parepally, Haranath and Brar, Jaspreet S. and Mullen, Jamie and Shilling, Ann and Goldstein, Jeffrey M.},
	year = {2003},
	month = {04},
	date = {2003-04},
	journal = {Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie},
	pages = {187--194},
	volume = {48},
	number = {3},
	doi = {10.1177/070674370304800307},
	note = {PMID: 12728743},
	langid = {eng}
}

@article{bauer2009,
	title = {Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study},
	author = {Bauer, Michael and Pretorius, Herman W. and Constant, Eric L. and Earley, Willie R. and Szamosi, Johan and Brecher, Martin},
	year = {2009},
	month = {04},
	date = {2009-04},
	journal = {The Journal of Clinical Psychiatry},
	pages = {540--549},
	volume = {70},
	number = {4},
	doi = {10.4088/jcp.08m04629},
	note = {PMID: 19358791},
	langid = {eng}
}

@article{sanford2012,
	title = {Quetiapine: a review of its use in the management of bipolar depression},
	author = {Sanford, Mark and Keating, Gillian M.},
	year = {2012},
	month = {05},
	date = {2012-05-01},
	journal = {CNS drugs},
	pages = {435--460},
	volume = {26},
	number = {5},
	doi = {10.2165/11203840-000000000-00000},
	note = {PMID: 22519923},
	langid = {eng}
}

@article{karsten2017,
	title = {Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial},
	author = {Karsten, Julie and Hagenauw, Loes A. and Kamphuis, Jeanine and Lancel, Marike},
	year = {2017},
	month = {03},
	date = {2017-03},
	journal = {Journal of Psychopharmacology (Oxford, England)},
	pages = {327--337},
	volume = {31},
	number = {3},
	doi = {10.1177/0269881116681399},
	note = {PMID: 28093029},
	langid = {eng}
}

@article{anderson2014,
	title = {Quetiapine for insomnia: A review of the literature},
	author = {Anderson, Sarah L. and Vande Griend, Joseph P.},
	year = {2014},
	month = {03},
	date = {2014-03-01},
	journal = {American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists},
	pages = {394--402},
	volume = {71},
	number = {5},
	doi = {10.2146/ajhp130221},
	note = {PMID: 24534594},
	langid = {eng}
}

@article{brett2015,
	title = {Concerns about quetiapine},
	author = {Brett, Jonathan},
	year = {2015},
	month = {06},
	date = {2015-06},
	journal = {Australian Prescriber},
	pages = {95--97},
	volume = {38},
	number = {3},
	doi = {10.18773/austprescr.2015.032},
	note = {PMID: 26648630
PMCID: PMC4653966},
	langid = {eng}
}

@article{kim2017,
	title = {Quetiapine Misuse and Abuse: Is it an Atypical Paradigm of Drug Seeking Behavior?},
	author = {Kim, Sean and Lee, Gayoung and Kim, Eric and Jung, Hyejin and Chang, Jongwha},
	year = {2017},
	month = {03},
	date = {2017-03},
	journal = {Journal of Research in Pharmacy Practice},
	pages = {12--15},
	volume = {6},
	number = {1},
	doi = {10.4103/2279-042X.200987},
	note = {PMID: 28331860
PMCID: PMC5348850},
	langid = {eng}
}

@article{tanne2010,
	title = {AstraZeneca pays {\$}520m fine for off label marketing},
	author = {Tanne, J. H.},
	year = {2010},
	month = {04},
	date = {2010-04-29},
	journal = {BMJ},
	pages = {c2380--c2380},
	volume = {340},
	number = {apr29 3},
	doi = {10.1136/bmj.c2380},
	url = {https://www.bmj.com/lookup/doi/10.1136/bmj.c2380},
	langid = {en}
}

@article{lee2018,
	title = {Increasing rates of quetiapine overdose, misuse, and mortality in Victoria, Australia},
	author = {Lee, Julia and Pilgrim, Jennifer and Gerostamoulos, Dimitri and Robinson, Jeff and Wong, Anselm},
	year = {2018},
	month = {06},
	date = {2018-06},
	journal = {Drug and Alcohol Dependence},
	pages = {95--99},
	volume = {187},
	doi = {10.1016/j.drugalcdep.2018.03.002},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0376871618301698},
	langid = {en}
}

@article{papazisis2012,
	title = {Sudden cardiac death due to quetiapine overdose: Letters to the Editor},
	author = {Papazisis, Georgios and Mastrogianni, Orthodoxia and Chatzinikolaou, Fotios and Vasiliadis, Nikolaos and Raikos, Nikolaos},
	year = {2012},
	month = {10},
	date = {2012-10},
	journal = {Psychiatry and Clinical Neurosciences},
	pages = {535--535},
	volume = {66},
	number = {6},
	doi = {10.1111/j.1440-1819.2012.02385.x},
	url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1440-1819.2012.02385.x},
	langid = {en}
}

@article{hasnain2014,
	title = {Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports},
	author = {Hasnain, Mehrul and Vieweg, W. Victor R. and Howland, Robert H. and Kogut, Christopher and Breden Crouse, Ericka L. and Koneru, Jayanthi N. and Hancox, Jules C. and Digby, {Geneviève C.} and Baranchuk, Adrian and Deshmukh, Anand and Pandurangi, Ananda K.},
	year = {2014},
	month = {06},
	date = {2014-06},
	journal = {Therapeutic Advances in Psychopharmacology},
	pages = {130--138},
	volume = {4},
	number = {3},
	doi = {10.1177/2045125313510194},
	note = {PMID: 25057346
PMCID: PMC4107702},
	langid = {eng}
}

@article{schmidt2001,
	title = {Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile},
	author = {Schmidt, A. W. and Lebel, L. A. and Howard, H. R. and Zorn, S. H.},
	year = {2001},
	month = {08},
	date = {2001-08-17},
	journal = {European Journal of Pharmacology},
	pages = {197--201},
	volume = {425},
	number = {3},
	doi = {10.1016/s0014-2999(01)01188-8},
	note = {PMID: 11513838},
	langid = {eng}
}

@article{stahl2003,
	title = {The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice},
	author = {Stahl, Stephen M. and Shayegan, Darius K.},
	year = {2003},
	date = {2003},
	journal = {The Journal of Clinical Psychiatry},
	pages = {6--12},
	volume = {64 Suppl 19},
	note = {PMID: 14728084},
	langid = {eng}
}

@article{gandelman2009,
	title = {The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial},
	author = {Gandelman, Kuan and Alderman, Jeffrey A. and Glue, Paul and Lombardo, Ilise and LaBadie, Robert R. and Versavel, Mark and Preskorn, Sheldon H.},
	year = {2009},
	month = {01},
	date = {2009-01},
	journal = {The Journal of Clinical Psychiatry},
	pages = {58--62},
	volume = {70},
	number = {1},
	doi = {10.4088/jcp.08m04104},
	note = {PMID: 19026256},
	langid = {eng}
}

@article{mamo2004,
	title = {A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone},
	author = {Mamo, David and Kapur, Shitij and Shammi, C. M. and Papatheodorou, George and Mann, Steve and Therrien, {François} and Remington, Gary},
	year = {2004},
	month = {05},
	date = {2004-05},
	journal = {The American Journal of Psychiatry},
	pages = {818--825},
	volume = {161},
	number = {5},
	doi = {10.1176/appi.ajp.161.5.818},
	note = {PMID: 15121646},
	langid = {eng}
}

@article{arango2007,
	title = {A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia},
	author = {Arango, C. and {Gómez-Beneyto}, M. and Brenlla, J. and {Gastó}, C. and Sarramea-Crespo, F. and Chamorro, L. and Masramon, X. and {Díez}, T. and ZIS Study Group, },
	year = {2007},
	month = {06},
	date = {2007-06},
	journal = {European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology},
	pages = {456--463},
	volume = {17},
	number = {6-7},
	doi = {10.1016/j.euroneuro.2006.11.007},
	note = {PMID: 17234389},
	langid = {eng}
}

@article{joyce2006,
	title = {Effect of initial ziprasidone dose on length of therapy in schizophrenia},
	author = {Joyce, Amie T. and Harrison, David J. and Loebel, Antony D. and Carter, Chureen T. and Ollendorf, Daniel A.},
	year = {2006},
	month = {04},
	date = {2006-04},
	journal = {Schizophrenia Research},
	pages = {285--292},
	volume = {83},
	number = {2-3},
	doi = {10.1016/j.schres.2006.01.009},
	note = {PMID: 16545543},
	langid = {eng}
}

@article{mullins2006,
	title = {Effect of initial ziprasidone dose on treatment persistence in schizophrenia},
	author = {Mullins, C. Daniel and Shaya, Fadia T. and Zito, Julie Magno and Obeidat, Nour and Naradzay, John and Harrison, David J.},
	year = {2006},
	month = {04},
	date = {2006-04},
	journal = {Schizophrenia Research},
	pages = {277--284},
	volume = {83},
	number = {2-3},
	doi = {10.1016/j.schres.2006.01.013},
	note = {PMID: 16545945},
	langid = {eng}
}

@article{citrome2009,
	title = {Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?},
	author = {Citrome, Leslie and Kantrowitz, Joshua T},
	year = {2009},
	month = {07},
	date = {2009-07},
	journal = {Expert Review of Neurotherapeutics},
	pages = {1045{\textendash}1058},
	volume = {9},
	number = {7},
	doi = {10.1586/ern.09.54},
	url = {http://dx.doi.org/10.1586/ern.09.54}
}

@article{camm2012,
	title = {Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data},
	author = {Camm, A. John and Karayal, Onur N. and Meltzer, Herbert and Kolluri, Sheela and {O'Gorman}, Cedric and Miceli, Jeffrey and Tensfeldt, Thomas and Kane, John M.},
	year = {2012},
	month = {04},
	date = {2012-04-01},
	journal = {CNS drugs},
	pages = {351--365},
	volume = {26},
	number = {4},
	doi = {10.2165/11599010-000000000-00000},
	note = {PMID: 22452529},
	langid = {eng}
}

@article{miceli2010,
	title = {Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder},
	author = {Miceli, Jeffrey J. and Tensfeldt, Thomas G. and Shiovitz, Thomas and Anziano, Richard and {O'Gorman}, Cedric and Harrigan, Rachel H.},
	year = {2010},
	month = {02},
	date = {2010-02},
	journal = {Pharmacotherapy},
	pages = {127--135},
	volume = {30},
	number = {2},
	doi = {10.1592/phco.30.2.127},
	note = {PMID: 20099987},
	langid = {eng}
}

@article{strom2011,
	title = {Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)},
	author = {Strom, Brian L. and Eng, Sybil M. and Faich, Gerald and Reynolds, Robert F. and {D'Agostino}, Ralph B. and Ruskin, Jeremy and Kane, John M.},
	year = {2011},
	month = {02},
	date = {2011-02},
	journal = {The American Journal of Psychiatry},
	pages = {193--201},
	volume = {168},
	number = {2},
	doi = {10.1176/appi.ajp.2010.08040484},
	note = {PMID: 21041245},
	langid = {eng}
}

@article{goff2013,
	title = {High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms},
	author = {Goff, Donald C. and McEvoy, Joseph P. and Citrome, Leslie and Mech, Arnold W. and Bustillo, Juan R. and Gil, Roberto and Buckley, Peter and Manschreck, Theo C. and Achtyes, Eric D. and Macklin, Eric A.},
	year = {2013},
	month = {08},
	date = {2013-08},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {485{\textendash}490},
	volume = {33},
	number = {4},
	doi = {10.1097/jcp.0b013e3182977308},
	url = {http://dx.doi.org/10.1097/JCP.0b013e3182977308}
}

@article{weiden2002,
	title = {Best clinical practice with ziprasidone: update after one year of experience},
	author = {Weiden, Peter J. and Iqbal, Naveed and Mendelowitz, Alan J. and Tandon, Rajiv and Zimbroff, Dan L. and Ross, Ruth},
	year = {2002},
	month = {03},
	date = {2002-03},
	journal = {Journal of Psychiatric Practice},
	pages = {81--97},
	volume = {8},
	number = {2},
	doi = {10.1097/00131746-200203000-00004},
	note = {PMID: 15985861},
	langid = {eng}
}

@article{pozzi2002,
	title = {Stimulation of 5-hydroxytryptamine (5-HT(2C) ) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex},
	author = {Pozzi, Laura and Acconcia, Sabrina and Ceglia, Ilaria and Invernizzi, Roberto W. and Samanin, Rosario},
	year = {2002},
	month = {07},
	date = {2002-07},
	journal = {Journal of Neurochemistry},
	pages = {93--100},
	volume = {82},
	number = {1},
	doi = {10.1046/j.1471-4159.2002.00947.x},
	note = {PMID: 12091469},
	langid = {eng}
}

@article{komossa2009,
	title = {Ziprasidone versus other atypical antipsychotics for schizophrenia},
	author = {Komossa, Katja and Rummel-Kluge, Christine and Hunger, Heike and Schwarz, Sandra and Bhoopathi, Paranthaman Seth S. and Kissling, Werner and Leucht, Stefan},
	year = {2009},
	month = {10},
	date = {2009-10-07},
	journal = {The Cochrane Database of Systematic Reviews},
	pages = {CD006627},
	number = {4},
	doi = {10.1002/14651858.CD006627.pub2},
	note = {PMID: 19821380
PMCID: PMC4164848},
	langid = {eng}
}

@article{gómezrevuelta2020,
	title = {Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone},
	author = {{Gómez-Revuelta}, Marcos and {Pelayo-Terán}, {José María} and Juncal-Ruiz, {María} and {Vázquez-Bourgon}, Javier and {Suárez-Pinilla}, Paula and {Romero-Jiménez}, Rodrigo and {Setién Suero}, Esther and Ayesa-Arriola, Rosa and Crespo-Facorro, Benedicto},
	year = {2020},
	month = {04},
	date = {2020-04-23},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {217--229},
	volume = {23},
	number = {4},
	doi = {10.1093/ijnp/pyaa004},
	note = {PMID: 31974576
PMCID: PMC7177160},
	langid = {eng}
}

@inbook{vardanyan2016,
	title = {Antipsychotics},
	author = {Vardanyan, Ruben and Hruby, Victor},
	editor = {Vardanyan, Ruben and Hruby, Victor},
	year = {2016},
	month = {01},
	date = {2016-01-01},
	publisher = {Academic Press},
	pages = {87--110},
	doi = {10.1016/B978-0-12-411492-0.00006-7},
	url = {https://www.sciencedirect.com/science/article/pii/B9780124114920000067},
	note = {DOI: 10.1016/B978-0-12-411492-0.00006-7},
	address = {Boston},
	langid = {en}
}

@article{carrière2000,
	title = {Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group)},
	author = {{Carrière}, P. and Bonhomme, D. and {Lempérière}, T.},
	year = {2000},
	month = {08},
	date = {2000-08},
	journal = {European Psychiatry: The Journal of the Association of European Psychiatrists},
	pages = {321--329},
	volume = {15},
	number = {5},
	doi = {10.1016/s0924-9338(00)00401-6},
	note = {PMID: 11032464},
	langid = {eng}
}

@article{peuskens1999,
	title = {Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group},
	author = {Peuskens, J. and Bech, P. and {Möller}, H. J. and Bale, R. and Fleurot, O. and Rein, W.},
	year = {1999},
	month = {11},
	date = {1999-11-08},
	journal = {Psychiatry Research},
	pages = {107--117},
	volume = {88},
	number = {2},
	doi = {10.1016/s0165-1781(99)00075-x},
	note = {PMID: 10622347},
	langid = {eng}
}

@article{danion1999,
	title = {Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group},
	author = {Danion, J. M. and Rein, W. and Fleurot, O.},
	year = {1999},
	month = {04},
	date = {1999-04},
	journal = {The American Journal of Psychiatry},
	pages = {610--616},
	volume = {156},
	number = {4},
	doi = {10.1176/ajp.156.4.610},
	note = {PMID: 10200742},
	langid = {eng}
}

@article{curran2001,
	title = {Amisulpride: A Review of its Use in the Management of Schizophrenia},
	author = {Curran, Monique P. and Perry, Caroline M.},
	year = {2001},
	date = {2001},
	journal = {Drugs},
	pages = {2123--2150},
	volume = {61},
	number = {14},
	doi = {10.2165/00003495-200161140-00014},
	url = {http://link.springer.com/10.2165/00003495-200161140-00014},
	langid = {en}
}

@article{martinot1996,
	title = {In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia},
	author = {Martinot, J. L. and {Paillère-Martinot}, M. L. and Poirier, M. F. and Dao-Castellana, M. H. and {Loc'h}, C. and {Mazière}, B.},
	year = {1996},
	month = {03},
	date = {1996-03},
	journal = {Psychopharmacology},
	pages = {154--158},
	volume = {124},
	number = {1-2},
	doi = {10.1007/BF02245616},
	note = {PMID: 8935811},
	langid = {eng}
}

@article{abbas2009,
	title = {Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo},
	author = {Abbas, Atheir I. and Hedlund, Peter B. and Huang, Xi-Ping and Tran, Thuy B. and Meltzer, Herbert Y. and Roth, Bryan L.},
	year = {2009},
	month = {07},
	date = {2009-07},
	journal = {Psychopharmacology},
	pages = {119--128},
	volume = {205},
	number = {1},
	doi = {10.1007/s00213-009-1521-8},
	note = {PMID: 19337725
PMCID: PMC2821721},
	langid = {eng}
}

@article{perrault1997,
	title = {Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity},
	author = {Perrault, G. and Depoortere, R. and Morel, E. and Sanger, D. J. and Scatton, B.},
	year = {1997},
	month = {01},
	date = {1997-01},
	journal = {The Journal of Pharmacology and Experimental Therapeutics},
	pages = {73--82},
	volume = {280},
	number = {1},
	note = {PMID: 8996184},
	langid = {eng}
}

@article{barrus2016,
	title = {Dopamine D {\textsubscript{3}} Receptors Modulate the Ability of Win-Paired Cues to Increase Risky Choice in a Rat Gambling Task},
	author = {Barrus, Michael M. and Winstanley, Catharine A.},
	year = {2016},
	month = {01},
	date = {2016-01-20},
	journal = {The Journal of Neuroscience},
	pages = {785--794},
	volume = {36},
	number = {3},
	doi = {10.1523/JNEUROSCI.2225-15.2016},
	url = {https://www.jneurosci.org/lookup/doi/10.1523/JNEUROSCI.2225-15.2016},
	langid = {en}
}

@article{diciano2015,
	title = {The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task},
	author = {Di Ciano, Patricia and Pushparaj, Abhiram and Kim, Aaron and Hatch, Jessica and Masood, Talal and Ramzi, Abby and Khaled, Maram A. T. M. and Boileau, Isabelle and Winstanley, Catherine A. and Le Foll, Bernard},
	editor = {McCutcheon, James Edgar},
	year = {2015},
	month = {09},
	date = {2015-09-09},
	journal = {PLOS ONE},
	pages = {e0136267},
	volume = {10},
	number = {9},
	doi = {10.1371/journal.pone.0136267},
	url = {https://dx.plos.org/10.1371/journal.pone.0136267},
	langid = {en}
}

@article{brevers2013,
	title = {Iowa Gambling Task (IGT): twenty years after {\textendash} gambling disorder and IGT},
	author = {Brevers, Damien and Bechara, Antoine and Cleeremans, Axel and {Noël}, Xavier},
	year = {2013},
	date = {2013},
	journal = {Frontiers in Psychology},
	volume = {4},
	doi = {10.3389/fpsyg.2013.00665},
	url = {http://journal.frontiersin.org/article/10.3389/fpsyg.2013.00665/abstract}
}

@article{kahn2008,
	title = {Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial},
	author = {Kahn, {René S} and Fleischhacker, W Wolfgang and Boter, Han and Davidson, Michael and Vergouwe, Yvonne and Keet, Ireneus PM and Gheorghe, Mihai D and Rybakowski, Janusz K and Galderisi, Silvana and Libiger, Jan and Hummer, Martina and Dollfus, Sonia and {López-Ibor}, Juan J and Hranov, Luchezar G and Gaebel, Wolfgang and Peuskens, Joseph and Lindefors, Nils and {Riecher-Rössler}, Anita and Grobbee, Diederick E},
	year = {2008},
	month = {03},
	date = {2008-03},
	journal = {The Lancet},
	pages = {1085--1097},
	volume = {371},
	number = {9618},
	doi = {10.1016/S0140-6736(08)60486-9},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0140673608604869},
	langid = {en}
}

@article{boter2009,
	title = {Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST)},
	author = {Boter, Han and Peuskens, Joseph and Libiger, Jan and Fleischhacker, W. Wolfgang and Davidson, Michael and Galderisi, Silvana and Kahn, {René S.}},
	year = {2009},
	month = {12},
	date = {2009-12},
	journal = {Schizophrenia Research},
	pages = {97{\textendash}103},
	volume = {115},
	number = {2-3},
	doi = {10.1016/j.schres.2009.09.019},
	url = {http://dx.doi.org/10.1016/j.schres.2009.09.019}
}

@article{kahn2018,
	title = {Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study},
	author = {Kahn, {René S.} and Winter van Rossum, Inge and Leucht, Stefan and McGuire, Philip and Lewis, Shon W. and Leboyer, Marion and Arango, Celso and Dazzan, Paola and Drake, Richard and Heres, Stephan and {Díaz-Caneja}, Covadonga M. and Rujescu, Dan and Weiser, Mark and Galderisi, Silvana and {Glenthøj}, Birte and Eijkemans, Marinus J. C. and Fleischhacker, W. Wolfgang and Kapur, Shitij and Sommer, Iris E. and OPTiMiSE study group, },
	year = {2018},
	month = {10},
	date = {2018-10},
	journal = {The Lancet. Psychiatry},
	pages = {797--807},
	volume = {5},
	number = {10},
	doi = {10.1016/S2215-0366(18)30252-9},
	note = {PMID: 30115598},
	langid = {eng}
}

@article{johnsen2020,
	title = {Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial},
	author = {Johnsen, Erik and Kroken, Rune A. and {Løberg}, Else-Marie and Rettenbacher, Maria and Joa, Inge and Larsen, Tor Ketil and Reitan, {Solveig Klæbo} and Walla, Berit and Alisauskiene, Renata and Anda, {Liss Gøril} and Bartz-Johannessen, Christoffer and Berle, {Jan Øystein} and Bjarke, Jill and Fathian, Farivar and Hugdahl, Kenneth and Kjelby, Eirik and Sinkeviciute, Igne and Skrede, Silje and Stabell, Lena and Steen, Vidar M. and Fleischhacker, W. Wolfgang},
	year = {2020},
	month = {11},
	date = {2020-11},
	journal = {The Lancet. Psychiatry},
	pages = {945--954},
	volume = {7},
	number = {11},
	doi = {10.1016/S2215-0366(20)30341-2},
	note = {PMID: 33069317},
	langid = {eng}
}

@article{huhn2019,
	title = {Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis},
	author = {Huhn, Maximilian and Nikolakopoulou, Adriani and Schneider-Thoma, Johannes and Krause, Marc and Samara, Myrto and Peter, Natalie and Arndt, Thomas and {Bäckers}, Lio and Rothe, Philipp and Cipriani, Andrea and Davis, John and Salanti, Georgia and Leucht, Stefan},
	year = {2019},
	month = {09},
	date = {2019-09},
	journal = {The Lancet},
	pages = {939--951},
	volume = {394},
	number = {10202},
	doi = {10.1016/S0140-6736(19)31135-3},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0140673619311353},
	langid = {en}
}

@article{barnes2017,
	title = {Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness},
	author = {Barnes, Thomas Re and Leeson, Verity C. and Paton, Carol and Marston, Louise and Davies, Linda and Whittaker, William and Osborn, David and Kumar, Raj and Keown, Patrick and Zafar, Rameez and Iqbal, Khalid and Singh, Vineet and Fridrich, Pavel and Fitzgerald, Zachary and Bagalkote, Hemant and Haddad, Peter M. and Husni, Mariwan and Amos, Tim},
	year = {2017},
	month = {09},
	date = {2017-09},
	journal = {Health Technology Assessment (Winchester, England)},
	pages = {1--56},
	volume = {21},
	number = {49},
	doi = {10.3310/hta21490},
	note = {PMID: 28869006
PMCID: PMC5601255},
	langid = {eng}
}

@article{zink2004,
	title = {Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature},
	author = {Zink, Mathias and Knopf, Udo and Henn, Fritz A. and Thome, Johannes},
	year = {2004},
	month = {01},
	date = {2004-01},
	journal = {Pharmacopsychiatry},
	pages = {26--31},
	volume = {37},
	number = {1},
	doi = {10.1055/s-2004-815471},
	note = {PMID: 14750045},
	langid = {eng}
}

@article{barnes2018,
	title = {Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial},
	author = {Barnes, Thomas R. E. and Leeson, Verity and Paton, Carol and Marston, Louise and Osborn, David P. and Kumar, Raj and Keown, Patrick and Zafar, Rameez and Iqbal, Khalid and Singh, Vineet and Fridrich, Pavel and Fitzgerald, Zachary and Bagalkote, Hemant and Haddad, Peter M. and Husni, Mariwan and Amos, Tim},
	year = {2018},
	month = {07},
	date = {2018-07},
	journal = {Therapeutic Advances in Psychopharmacology},
	pages = {185--197},
	volume = {8},
	number = {7},
	doi = {10.1177/2045125318762365},
	note = {PMID: 29977519
PMCID: PMC6022882},
	langid = {eng}
}

@article{leucht2002,
	title = {Amisulpride, an Unusual {"}Atypical{"} Antipsychotic: A Meta-Analysis of Randomized Controlled Trials},
	author = {Leucht, S.},
	year = {2002},
	month = {02},
	date = {2002-02-01},
	journal = {American Journal of Psychiatry},
	pages = {180--190},
	volume = {159},
	number = {2},
	doi = {10.1176/appi.ajp.159.2.180},
	url = {http://ajp.psychiatryonline.org/article.aspx?articleID=175327}
}

@article{zhang2020,
	title = {Efficacy of amisulpride on postoperative nausea and vomiting: a systematic review and meta-analysis},
	author = {Zhang, Lu-Feng and Zhang, Chao-Fan and Tang, Wen-Xin and He, Long and Liu, Yang and Tian, Dan-Dan and Ai, Yan-Qiu},
	year = {2020},
	month = {07},
	date = {2020-07},
	journal = {European Journal of Clinical Pharmacology},
	pages = {903--912},
	volume = {76},
	number = {7},
	doi = {10.1007/s00228-020-02869-1},
	note = {PMID: 32274525},
	langid = {eng}
}

@article{grattan2019,
	title = {Antipsychotic Benzamides Amisulpride and LB-102 Display Polypharmacy as Racemates, {\emph{S}} Enantiomers Engage Receptors D {\textsubscript{2}} and D {\textsubscript{3}} , while {\emph{R}} Enantiomers Engage 5-HT {\textsubscript{7}}},
	author = {Grattan, Vincent and Vaino, Andrew R. and Prensky, Zachary and Hixon, Mark S.},
	year = {2019},
	month = {08},
	date = {2019-08-27},
	journal = {ACS Omega},
	pages = {14151--14154},
	volume = {4},
	number = {9},
	doi = {10.1021/acsomega.9b02144},
	url = {https://pubs.acs.org/doi/10.1021/acsomega.9b02144},
	langid = {en}
}
